RxDoctor Payments Data

Stacy Abernathy, MD

Hospice and Palliative Medicine · Dallas, TXNPI 1346335593

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $59, 4.9 times the $12 reported in 2021.

$147in general payments, 2019–2025

Across 8 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$25
  • Geron Corporation$24
  • Merck$21
  • Stemline Therapeutics Inc.$19
  • Blueprint Medicines Corporation$16
  • Karyopharm Therapeutics Inc.$16
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$147 in reported general payments places this provider in the 60th percentile of 136 hospice and palliative medicine providers in Texas.

See all hospice and palliative medicine providers in Texas

Medicare billing

Part B allowed, 2024
$64,243
Medicare patients
86
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl130$10,730
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen231$9,453
OxycontinOxycodone Hcl23$9,216
Morphine Sulfate ErMorphine Sulfate203$6,646
Hydromorphone Hcl98$4,137
Oxycodone Hcl162$3,290
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen74$2,723
Morphine Sulfate73$2,253
Mirtazapine95$1,266
Gabapentin72$668
Ondansetron OdtOndansetron31$526
Ondansetron Hcl43$427
Methadone Hcl25$397
Pregabalin21$320
Duloxetine Hcl18$292

Paid to pharmacies, not to this prescriber.

Other hospice and palliative medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →